Concise review: heart regeneration and the role of cardiac stem cells

Area of Science:

• Cardiology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Acute myocardial infarction causes irreversible cardiac myocyte loss, impairing heart function and leading to chronic heart failure (CHF).
• The mammalian heart exhibits regenerative capacity in neonatal stages, with evidence suggesting potential persistence in adulthood.
• Cardiac stem/progenitor cells (CSCs) are multipotent cells within the heart capable of differentiating into cardiomyocytes and vascular cells.

Purpose of the Study:

• To review the current status of the cardioregenerative field, focusing on cardiac stem/progenitor cells (CSCs).
• To summarize knowledge regarding CSCs as a regenerative substrate in the adult heart.
• To discuss the application of CSCs in preclinical and clinical studies for myocardial repair.

Main Methods:

• Literature review of existing research on cardiac regeneration and CSCs.
• Synthesis of data from preclinical and clinical studies involving CSC transplantation or in situ stimulation.
• Analysis of CSC differentiation potential and limitations in repairing infarcted myocardium.

Main Results:

• CSCs possess the inherent potential for cardiac regeneration but are insufficient to counteract extensive cell loss post-myocardial infarction.
• Preclinical and clinical studies are exploring CSC-based strategies to repair injured heart tissue.
• Optimizing CSC utilization or in situ stimulation is vital for effective cardioregenerative therapies.

Conclusions:

• Cardiac stem/progenitor cells represent a promising avenue for therapeutic cardiac regeneration.
• Despite their potential, current CSC-based approaches face challenges in treating significant myocardial damage.
• Continued research into CSC biology and therapeutic application is essential for advancing chronic heart failure treatment.